Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Windia-M Tablet ER

Prescription Icon
Prescription Required

Marketer

Dr. Ethix's Product & Services Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Windia-M Tablet ER

Diabetic patients utilizing GlycoDuo ER tablets, a dual-action antidiabetic medication, manage type 2 diabetes mellitus. This formulation effectively regulates blood glucose in adults. GlycoDuo ER should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on glucose monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Prompt glucose intake (e.g., sugary foods or juice) is essential for hypoglycemia management. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects encompass altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.

Uses of Windia-M Tablet ER

Adult-onset diabetes

Major Benefits of Windia-M Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Windia-M Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Windia-M Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Windia-M Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Windia-M Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This extended-release medication should be administered with a meal.

How Windia-M Tablet ER works:

Windia-M Extended-Release tablets contain a dual-action formulation of gliclazide and metformin, both used in diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Windia-M Extended-Release tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Windia-M tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the known dangers. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Windia-M tablets are likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Windia-M Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Windia-M Tablet ER is contraindicated in patients exhibiting severe kidney disease. Close monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Windia-M Extended-Release Tablets. Dosage modification may be necessary. Physician consultation is advised. For individuals with mild to moderate hepatic dysfunction, a low initial dose of Windia-M Extended-Release Tablets is typically recommended; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Windia-M Tablet ER :

Should you forget a Windia-M Tablet ER dose, take it immediately if feasible. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Windia-M Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Windia-M Tablet ER

Windia-M ER tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Windia-M Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Windia-M Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Windia-M Tablet ER can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Windia-M Tablet ER and seek immediate medical attention.
Prolonged Windia-M Tablet ER use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Windia-M Tablet ER is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Windia-M Tablet ER and alcohol is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
Windia-M ER tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Windia-M Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Windia-M Tablet ER can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Windia-M Tablet ER can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Windia-M Tablet ER and seek immediate medical attention.
Prolonged Windia-M Tablet ER use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Windia-M Tablet ER is contraindicated in patients with known allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Windia-M ER tablets and alcohol is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Windia-M Tablet ER
251
MRP 290
13% off